Table 3.
PGL | Nodal Metastasis | Schwannoma | Neurofibroma | |
---|---|---|---|---|
MRI | Flow voids (salt-and-pepper appearance on T2-weighted images) | Variable appearance on spin-echo images | Moderate to high signal intensity on T2 | Moderate to high signal intensity on T2 Central low signal on T2 may be seen (target sign) |
Rapid (numerous arterial feeders), intense and homogeneous enhancement | Heterogeneous enhancement | Heterogeneous enhancement in large tumors with degenerative changes (cystic, pseudocystic) | Moderate and delayed homogeneous enhancement | |
[18F]FDG | Moderate to high uptake (highly elevated in SDHx-tumors) | Low to high uptake depending on the primary tumor | Low to high uptake (even in benign cases) | Low uptake (high uptake values in malignant forms) |
[18F]FDOPA | High uptake | No significant uptake | No significant uptake | No significant uptake |
SST-based imaginga | High uptake | No significant uptake (possible high uptake in nodal metastases from thyroid cancers of follicular origin or nasopharyngeal cancers) | No significant uptake | No significant uptake |
SST-based imaging is somatostatin receptor imaging with octreoscan or 68Ga-labeled somatostatin analogs.